PL2932264T3 - Nowe niezależne od MHC antygeny powiązane z nowotworem - Google Patents
Nowe niezależne od MHC antygeny powiązane z nowotworemInfo
- Publication number
- PL2932264T3 PL2932264T3 PL13818713T PL13818713T PL2932264T3 PL 2932264 T3 PL2932264 T3 PL 2932264T3 PL 13818713 T PL13818713 T PL 13818713T PL 13818713 T PL13818713 T PL 13818713T PL 2932264 T3 PL2932264 T3 PL 2932264T3
- Authority
- PL
- Poland
- Prior art keywords
- associated antigens
- independent tumor
- novel mhc
- mhc
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001116—Receptors for cytokines
- A61K39/001118—Receptors for colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001154—Enzymes
- A61K39/001156—Tyrosinase and tyrosinase related proteinases [TRP-1 or TRP-2]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/03—Intramolecular oxidoreductases (5.3) transposing C=C bonds (5.3.3)
- C12Y503/03012—L-Dopachrome isomerase (5.3.3.12)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197289 | 2012-12-14 | ||
| EP13818713.3A EP2932264B1 (en) | 2012-12-14 | 2013-12-16 | Novel mhc-independent tumor-associated antigens |
| PCT/EP2013/076760 WO2014091034A1 (en) | 2012-12-14 | 2013-12-16 | Novel mhc-independent tumor-associated antigens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2932264T3 true PL2932264T3 (pl) | 2019-09-30 |
Family
ID=47355928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13818713T PL2932264T3 (pl) | 2012-12-14 | 2013-12-16 | Nowe niezależne od MHC antygeny powiązane z nowotworem |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9861688B2 (pl) |
| EP (1) | EP2932264B1 (pl) |
| JP (1) | JP6475166B2 (pl) |
| AU (2) | AU2013357239B2 (pl) |
| CA (2) | CA2894966C (pl) |
| DK (1) | DK2932264T3 (pl) |
| ES (1) | ES2721159T3 (pl) |
| HU (1) | HUE042967T2 (pl) |
| PL (1) | PL2932264T3 (pl) |
| PT (1) | PT2932264T (pl) |
| SI (1) | SI2932264T1 (pl) |
| TR (1) | TR201905447T4 (pl) |
| WO (1) | WO2014091034A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX428954B (es) | 2013-03-15 | 2025-11-13 | Univ Pennsylvania | Vacunación mejorada contra la hormona liberadora de la hormona de crecimiento (ghrh) humana. |
| JP7013240B2 (ja) | 2015-02-16 | 2022-01-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｈｅｒ２／Ｎｅｕ （ＥＲＢＢ２）受容体タンパク質に由来する３６９～３７７位エピトープに特異的な完全ヒトＴ細胞受容体 |
| SG11202007622SA (en) | 2018-02-11 | 2020-09-29 | Memorial Sloan Kettering Cancer Center | Non-hla restricted t cell receptors and uses thereof |
| EP3786178A1 (en) | 2019-08-30 | 2021-03-03 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Tcr constructs specific for ebv-derived antigens |
| CN116761813A (zh) * | 2020-10-27 | 2023-09-15 | T-Cure生物科学公司 | 结合ny-eso-1和/或lage-1a癌抗原的重组t细胞受体 |
| WO2022155375A2 (en) * | 2021-01-13 | 2022-07-21 | Washington University | MHC-INDEPENDENT TCRs AND METHODS OF MAKING AND USING SAME |
| JP2024529467A (ja) | 2021-07-27 | 2024-08-06 | イマティクス バイオテクノロジーズ ゲーエムベーハー | Ｃｔ４５に特異的に結合する抗原結合タンパク質 |
| EP4527849A1 (en) | 2023-09-19 | 2025-03-26 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz | Hla-independent antigen binders, such as t-cell receptors, against pd-l1 |
| WO2026159065A1 (en) * | 2025-01-27 | 2026-07-30 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz Körperschaft des öffentlichen Rechts | Hla-independent t-cell receptors against the urokinase receptor upar |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0486572T3 (da) * | 1989-08-11 | 1998-05-04 | Amrad Corp Ltd | Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf |
| US5840839A (en) | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| WO2002048370A2 (en) | 2000-10-31 | 2002-06-20 | Diadexus, Inc. | Compositions and methods relating to colon specific genes and proteins |
| KR101481844B1 (ko) * | 2006-03-27 | 2015-01-13 | 메디뮨 리미티드 | Ｇｍ-ｃｓｆ 수용체에 대한 결합 성분 |
| US20090304657A1 (en) | 2006-05-03 | 2009-12-10 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Chimeric t cell receptors and related materials and methods of use |
| WO2008039818A2 (en) | 2006-09-26 | 2008-04-03 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Modified t cell receptors and related materials and methods |
| EP2091967A4 (en) * | 2006-11-03 | 2010-05-05 | St Vincents Inst Med Res | CRYSTALLINE COMPOSITION OF GM-CSF / GM-CSFR |
| US8785601B2 (en) | 2009-01-28 | 2014-07-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
| WO2011029126A1 (en) * | 2009-09-14 | 2011-03-17 | Walter And Eliza Hall Institute Of Medical Research | Methods and reagents for producing antibodies against autoantigens |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
-
2013
- 2013-12-16 SI SI201331422T patent/SI2932264T1/sl unknown
- 2013-12-16 WO PCT/EP2013/076760 patent/WO2014091034A1/en not_active Ceased
- 2013-12-16 US US14/648,703 patent/US9861688B2/en active Active
- 2013-12-16 JP JP2015547067A patent/JP6475166B2/ja active Active
- 2013-12-16 AU AU2013357239A patent/AU2013357239B2/en active Active
- 2013-12-16 HU HUE13818713A patent/HUE042967T2/hu unknown
- 2013-12-16 PT PT13818713T patent/PT2932264T/pt unknown
- 2013-12-16 TR TR2019/05447T patent/TR201905447T4/tr unknown
- 2013-12-16 CA CA2894966A patent/CA2894966C/en active Active
- 2013-12-16 DK DK13818713.3T patent/DK2932264T3/da active
- 2013-12-16 EP EP13818713.3A patent/EP2932264B1/en active Active
- 2013-12-16 CA CA3108192A patent/CA3108192C/en active Active
- 2013-12-16 PL PL13818713T patent/PL2932264T3/pl unknown
- 2013-12-16 ES ES13818713T patent/ES2721159T3/es active Active
-
2017
- 2017-11-30 US US15/826,879 patent/US10987413B2/en active Active
-
2019
- 2019-09-25 AU AU2019236675A patent/AU2019236675B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3108192A1 (en) | 2014-06-19 |
| JP2016501268A (ja) | 2016-01-18 |
| SI2932264T1 (sl) | 2019-05-31 |
| US10987413B2 (en) | 2021-04-27 |
| US20180099033A1 (en) | 2018-04-12 |
| DK2932264T3 (da) | 2019-05-06 |
| AU2019236675A1 (en) | 2019-10-17 |
| AU2019236675B2 (en) | 2022-02-24 |
| CA2894966A1 (en) | 2014-06-19 |
| TR201905447T4 (tr) | 2019-05-21 |
| US9861688B2 (en) | 2018-01-09 |
| PT2932264T (pt) | 2019-05-21 |
| ES2721159T3 (es) | 2019-07-29 |
| EP2932264A1 (en) | 2015-10-21 |
| JP6475166B2 (ja) | 2019-02-27 |
| EP2932264B1 (en) | 2019-01-30 |
| AU2013357239A1 (en) | 2015-06-18 |
| WO2014091034A1 (en) | 2014-06-19 |
| US20150313978A1 (en) | 2015-11-05 |
| CA2894966C (en) | 2021-03-30 |
| CA3108192C (en) | 2026-02-24 |
| AU2013357239B2 (en) | 2019-10-17 |
| HUE042967T2 (hu) | 2019-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264558A (en) | Anti–il–23p19 antibodies | |
| IL235807A0 (en) | Immunoprecipitates containing anti–cd79b antibodies | |
| IL235989A0 (en) | Immunoprecipitates containing anti–cd79b antibodies | |
| HUE045652T2 (hu) | Antitest-készítmények | |
| ZA201407509B (en) | Anti-fcrn antibodies | |
| ZA201407897B (en) | Protease-regulated antibodies | |
| ZA201409358B (en) | Anti-siglec- 15 antibodies | |
| LT2906252T (lt) | Pirolobenzodiazepino-anti-her2 antikūno konjugatai | |
| SG11201504765VA (en) | Anti-h7cr antibodies | |
| PT2932264T (pt) | Novos antigénios independentes de mhc associados a tumor | |
| IL234883A0 (en) | CDR-modified anti-siglac-15 antibody | |
| GB201220242D0 (en) | Antibody | |
| EP2804876A4 (en) | NEW ANTIBODIES | |
| EP2811018A4 (en) | ANTI-BODY ANTI-sAPPß | |
| GB201216749D0 (en) | Antigen combinations | |
| GB201200568D0 (en) | Antigen combinations | |
| IL235188A0 (en) | Antibodies against c-pdgf | |
| GB201209584D0 (en) | Modified antibodies |